Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients [Phase 1]

View source ↗

Summary

This report covers a completed Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics after high single ascending oral doses of A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED